scispace - formally typeset
D

Dirk De Ruysscher

Researcher at Maastricht University

Publications -  598
Citations -  27156

Dirk De Ruysscher is an academic researcher from Maastricht University. The author has contributed to research in topics: Lung cancer & Radiation therapy. The author has an hindex of 76, co-authored 518 publications receiving 22378 citations. Previous affiliations of Dirk De Ruysscher include Universitaire Ziekenhuizen Leuven & University of Mainz.

Papers
More filters
Journal ArticleDOI

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

TL;DR: The Clatterbridge Cancer Centre and Liverpool Heart and Chest Hospital, Liverpool; University of Aberdeen, Aberdeen, UK; Center for Medical Imaging, University of Groningen, Groningen; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands; and Department of Thoracic Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
Journal ArticleDOI

Small Cell Lung Cancer

TL;DR: Combination chemotherapy, generally platinum-based plus etoposide or irinotecan, is the mainstay first-line treatment for metastatic small-cell lung cancer as discussed by the authors.
Journal ArticleDOI

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

TL;DR: In this article, a collaboration of multidisciplinary experts on the functional evaluation of lung cancer patients has been facilitated by the European Respiratory Society (ERS) and the European Society of Thoracic Surgery (ESTS), in order to draw up recommendations and provide clinicians with clear, up-to-date guidelines on fitness for surgery and chemo-radiotherapy.
Journal Article

Ers/ests clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) . a. brunelli, a. charloux, c.t. bolliger, g. rocco, j-p. sculier, g. varela

TL;DR: Clinical practice guidelines were generated and finalised in a functional algorithm for risk stratification of the lung resection candidates, emphasising cardiological evaluation, forced expiratory volume in 1 s, systematic carbon monoxide lung diffusion capacity and exercise testing.